Is Pacific Biosciences of California Inc (NASDAQ: PACB) Back In The Buying Zone?
Currently, there are 294.42M common shares owned by the public and among those 262.18M shares have been available to trade. The company’s stock has a 5-day price change of 11.86% and -33.67% over the past three months. PACB shares are trading -27.87% year to date (YTD), with the 12-month market performance down to -60.36% lower. […]
Look At Analyst Expectations For A Better Read On Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 294.42M common shares owned by the public and among those 263.27M shares have been available to trade. The company’s stock has a 5-day price change of -11.28% and -38.86% over the past three months. PACB shares are trading -35.52% year to date (YTD), with the 12-month market performance down to -68.28% lower. […]
Pacific Biosciences of California Inc (PACB): Insights At A Glance
Pacific Biosciences of California Inc (PACB) concluded trading on Wednesday at a closing price of $1.27, with 6.26 million shares of worth about $7.95 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -27.01% during that period and on March 26, 2025 the price […]
Handle With Care: Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 273.86M common shares owned by the public and among those 243.53M shares have been available to trade. The company’s stock has a 5-day price change of -10.79% and -45.37% over the past three months. PACB shares are trading -32.24% year to date (YTD), with the 12-month market performance down to -70.75% lower. […]
Gains May Be On The Menu For Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 273.86M common shares owned by the public and among those 243.53M shares have been available to trade. The company’s stock has a 5-day price change of 5.70% and -33.17% over the past three months. PACB shares are trading -24.04% year to date (YTD), with the 12-month market performance down to -66.71% lower. […]
Analyst Expect Big Moves From Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 273.86M common shares owned by the public and among those 243.51M shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
Growing Through Challenges? – Pacific Biosciences of California Inc (PACB)
Currently, there are 267.44M common shares owned by the public and among those 253.36M shares have been available to trade. Insiders at the company have transacted a total of 19 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
Pacific Biosciences of California Inc (NASDAQ: PACB) – Suitable For Long Term Buy?
Currently, there are 267.44M common shares owned by the public and among those 256.44M shares have been available to trade. Insiders at the company have transacted a total of 21 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
These Numbers Could Change Investor Views For Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 267.44M common shares owned by the public and among those 256.44M shares have been available to trade. Insiders at the company have transacted a total of 21 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
Pacific Biosciences of California Inc (PACB): Street Finally Waking Up
ARK Investment Management LLC recently announced the acquisition of new stake in Pacific Biosciences of California Inc (NASDAQ:PACB). The institutional investor has increased its shareholding in the Healthcare company by 15.70% to 34.5 million shares with purchase of 4.68 million shares. This fresh investment now brings its stake to 12.90% valued currently at $338.49 million. […]
